Alcohol abuse
Rare disease
No
- Definition
- The use of alcoholic beverages to excess, either on individual occasions ("binge drinking") or as a regular practice.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Alcohol abuse
- alcohol abuse
- alcohol abuse
- abuse, alcohol
- addiction, alcohol
- alcohol addiction
- alcohol dependence
- alcoholic intoxication, chronic
- alcoholism
- chronic alcoholic intoxication
- dependence, alcohol
- intoxication, chronic alcoholic
- Severity
- Severe
- MONDO ID
- MONDO:0002046
- Parent condition
- MONDO:0002491
Related records
Broader conditions (7)
- Alcohol-related disorders
- Disease
- Disease by developmental or physiological process
- Human disease
- Psychiatric disorder
- Substance abuse
- Substance-related disorder
Trials (1,173)
- "ALCO-VR": Virtual Reality Cue Exposure Therapy for the Treatment of Alcohol Use Disorder
- "Juego de LLaves": Study Protocol of a Universal School-based Drug Use Prevention Program (PSIDUP)
- [C-11]NOP-1A and Alcohol Use Disorder
- [C-11]PiB PET Imaging in Alcohol Use Disorders
- 90-Day Online Substance Use Program
- A Brief Alcohol Intervention for Incarcerated Women
- A Clinical Trial on the Efficacy of tDCS) in Reducing Alcohol Consumption in Non-abstinent Patients (REDSTIM)
- A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder
- A Community-Based Intervention to Reduce Alcohol Use in Vietnamese Men
- A Community-Based Strategy for Preventing Underage Drinking
- A Community-University Approach to Preventing HIV
- A Comparison of Adolescent Group Therapy and Transitional Family Therapy for Adolescent Alcohol and Drug Abusers
- A Critical Illness Recovery Navigator for Alcohol
- A Dialectical Behavioral Therapy Digital Health Solution for Outpatients Seeking Support for Substance Use
- A Digital Pill System to Measure and Support Acamprosate Adherence in Individuals With Alcohol Associated Liver Disease
- A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder
- A Feasibility and Acceptability Study of a Large Language Model-based Chatbot for Brief Alcohol Intervention Among Emerging Adults
- A Female-Specific CBT Group for Veteran Women With Alcohol Use Disorder in VA Primary Care Settings
- A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects
- A Gamified, Social Media Inspired Personalized Normative Feedback Alcohol Intervention for Sexual Minority Women
Approved drugs (1)
- Naltrexone
Drugs in development (26)
- Alcohol Phase 3
- Bupropion Phase 2
- Carisbamate Phase 1
- Citalopram Phase 2
- GET-73 Phase 2
- Guanfacine Phase 2
- Lefelsiran Phase 1
- Lefelsiran sodium Phase 1
- Levetiracetam Phase 3
- Mazdutide Phase 2
- Memantine Phase 2
- Mifepristone Phase 2
- Nimodipine Phase 2
- Ondansetron Phase 3
- ORG-34517 Phase 1
- Prazosin Phase 2
- Psilocybin Phase 2
- Puerarin Phase 2
- Quetiapine fumarate Phase 3
- Semaglutide Phase 3
Other linked drugs (6)
- Acamprosate
- Baclofen
- Cycloserine
- Disulfiram
- Dutasteride
- Methylphenidate